Geneva, Switzerland – August 12, 2008 – Geneva Bioinformatics (GeneBio) SA

today announced that the Sloan-Kettering Institute, part of the Memorial

Sloan-Kettering Cancer Center, has licensed GeneBio’s PhenyxServer protein

identification and characterization software to be used in the laboratory of

Paul Tempst, PhD.

Dr. Paul Tempst’s team is one of the five Clinical Proteomic Technology

Assessment for Cancer (CPTAC) teams, a collaborative network established by

the National Cancer Institute (NCI) whose goal is to enable all researchers

conducting cancer-related protein research at different laboratories to

effectively use proteomic technologies and methodologies to directly compare

and analyze their work.

Developed in collaboration with the Swiss Institute of Bioinformatics (SIB),

Phenyx is GeneBio’s comprehensive platform for protein identification and

characterization, including extensive PTM searches, results quantitation,

multiple results comparison, etc. Phenyx is specifically designed to meet

the concurrent demands of high-throughput MS data analysis and dynamic

results assessment while offering a flexible user experience and an

adaptable architecture to help instil confidence in results assessment.

(https://phenyx.vital-it.ch/pwi)

“We are excited to see how Phenyx matches up with other search engines in

the lab and our various projects,” said Paul Tempst, Lab Head of the Protein

Center which is a part of the Molecular Biology Research Program at the

Sloan-Kettering Institute.

“We are happy to have signed on Dr. Tempst’s group as a Phenyx user,” said

Nasri Nahas, CEO of GeneBio. “The Phenyx platform adds great value due to

its unique capabilities and level of flexibility; we are excited to provide

Paul’s team with the best possible scoring schemes in order for them to

truly take advantage of their data within the framework of their Proteomics

research studies.”

For more information concerning Phenyx, including product demonstrations,

please visit GeneBio’s booth (#103) at the upcoming HUPO 7th Annual World

Congress in Amsterdam, NL, from August 16-20.

About GeneBio

Geneva Bioinformatics (GeneBio) SA is a leading bioinformatics company

providing the life science community with world-class proteomics software

that bridges the gap between information gathering and knowledge generation.

Established in 1997, GeneBio focuses its expertise on protein identification

and characterization as well as proteome imaging, offering clients and

partners a high degree of specialization essential to proteomics research.

Close ties to academic peers and a thorough network of distribution and

strategic partners give the company both unfettered access to scientific

excellence and recognized market presence so that we may best serve the

scientific community. For more information about GeneBio, please visit:

www.genebio.com.